rss
Br J Ophthalmol 2007;91:1250-1251 doi:10.1136/bjo.2006.112532
  • Letter

Symptomatic interferon retinopathy successfully treated by hypertension management

  1. C Han1,
  2. J O’Day2
  1. 1
    St Vincent’s Hospital, Fitzroy, Australia
  2. 2
    Department of Neuro-opthalmology, Royal Victorian Eye and Ear Hospital, Melbourne, Australia
  1. Dr C Han, Department of Surgery, St Vincent’s Hospital, 41 Victoria Parade, Fitzroy, Melbourne, Australia 3065; charles.han{at}svhm.org.au
  • Accepted 11 December 2006

Retinopathy is a common side effect of interferon treatment. We report a case of symptomatic retinopathy caused by interferon α in a hypertensive patient successfully treated by management of hypertension alone and without stopping interferon α. As far as we know, this is the first reported case of interferon retinopathy successfully treated by hypertension management.

Pathogenesis of interferon retinopathy is most likely related to microcirculation damage and the impairment of angiogenesis. If interferon α therapy offers significant clinical benefit but is complicated by retinopathy, by treating other sources of microcirculation injury such as hypertension or diabetes mellitus, symptomatic retinopathy may be successfully treated without ceasing interferon α treatment.

Case report

The patient is a …

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.